AlphaCore Capital
BMY icon

AlphaCore Capital’s Bristol-Myers Squibb BMY Stock Holding History

AlphaCore Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.36M Buy
53,909
+7,520
+16% +$475K 0.05% 259
2026
Q2 		$2.67M Sell
46,389
-261
-0.6% -$15K 0.05% 271
2026
Q1 		$2.83M Buy
46,650
+6,004
+15% +$350K 0.07% 212
2025
Q4 		$2.19M Buy
40,646
+16,199
+66% +$779K 0.05% 254
2025
Q3 		$1.1M Buy
24,447
+1,952
+9% +$91.2K 0.04% 281
2025
Q2 		$1.04M Buy
22,495
+3,459
+18% +$170K 0.04% 255
2025
Q1 		$1.16M Buy
19,036
+354
+2% +$20.6K 0.1% 156
2024
Q4 		$1.06M Sell
18,682
-575
-3% -$32.1K 0.23% 74
2024
Q3 		$996K Sell
19,257
-2,919
-13% -$137K 0.22% 75
2024
Q2 		$921K Sell
22,176
-2,036
-8% -$91.1K 0.22% 72
2024
Q1 		$1.31M Buy
24,212
+1,964
+9% +$100K 0.35% 53
2023
Q4 		$1.14M Sell
22,248
-5,257
-19% -$276K 0.17% 92
2023
Q3 		$1.6M Sell
27,505
-14,025
-34% -$859K 0.25% 68
2023
Q2 		$2.66M Buy
41,530
+27,955
+206% +$1.87M 0.43% 50
2023
Q1 		$941K Buy
13,575
+103
+0.8% +$7.26K 0.25% 56
2022
Q4 		$969K Buy
13,472
+1,446
+12% +$109K 0.38% 31
2022
Q3 		$855K Buy
12,026
+3,392
+39% +$246K 0.39% 27
2022
Q2 		$665K Buy
8,634
+3,124
+57% +$238K 0.31% 35
2022
Q1 		$402K Buy
+5,510
New +$370K 0.16% 50
2020
Q2 		– Sell
-888
Closed -$49K – 99
2020
Q1 		$49K Buy
+888
New +$54.3K 0.04% 105

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

AlphaCore Capital's BMY Position: Q3 2026 in Review

AlphaCore Capital increased its Bristol-Myers Squibb (BMY) stake by 16% in Q3 2026, buying an estimated $475K and bringing the position to 53,909 shares worth $3.36M. The position accounts for 0.05% of the portfolio, ranked #259.

AlphaCore Capital first reported a position in BMY in Q1 2020 and has held it in 20 quarters since. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • AlphaCore Capital held 53,909 shares of Bristol-Myers Squibb worth $3.36M as of Q3 2026.
  • AlphaCore Capital bought 7,520 Bristol-Myers Squibb shares in Q3 2026, an estimated $475K.
  • Bristol-Myers Squibb made up 0.05% of AlphaCore Capital's portfolio in Q3 2026, its #259 holding.
  • AlphaCore Capital first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 20 quarters since.
  • 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on AlphaCore Capital's 13F filing for Q3 2026, filed 4 Nov 2026.